13F Pro quality score
Rank #332 of 2,925TOP 25%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
AI-extracted from the 10-Q filed 2026-10-23 — Q3 FY2026 (quarter ended September 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
CME Group's third-quarter total revenues rose 13% to $1,737.3M, driven by a 12% increase in clearing and transaction fees and 20% growth in market data and information services.
Net increases of $141.8M from change in total contract volume ($179.1M), partially offset by decreases from lower average rate per contract ($37.3M).
Largely due to higher usage of certain products, increased demand by new customer segments, and price increases for certain products.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Reported revenue, net income and operating margin by fiscal year, from CME GROUP INC.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $6.5B | $4.1B | 64.9% |
| FY 2024 | 10-K | $6.1B | $3.5B | 64.1% |
| FY 2023 | 10-K | $5.6B | $3.2B | 61.6% |
| FY 2022 | 10-K | $5.0B | $2.7B | 60.1% |
| FY 2021 | 10-K | $4.7B | $2.6B | 56.4% |
| FY 2020 | 10-K | $4.9B | $2.1B | 54.0% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
31 transactions in CME reported by 16 members of Congress under the STOCK Act, most recent trade Jun 16, 2026. Reported transactions, not recommendations.
CME GROUP INC. (CME) stock profile, AI quality score, and SEC EDGAR financial data, a Financials sector company. 13F Pro's AI-powered ranking engine scores CME at 67.9/100 on a composite quality score built from its SEC filings, placing it at rank #332 of 2,925 stocks — the top 25% of the AI-ranked universe. CME scores in the top quartile across profitability (98.3), free cash flow (97.1), revenue scale (82.6). Areas of concern include earnings quality (39.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q3 2026), CME GROUP INC. reports quarterly revenue of $1.7B, net income of $1.0B, an operating margin of 65.7%. Top institutional holders of CME by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. CME trades on the Nasdaq exchange and files with the SEC under CIK 1156375. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CME daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CME GROUP INC. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1156375 →